NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 901–1,000 of 1,014
Sricharoensuk, C., Boonchalermvichien, T., Muanwien, P., Somparn, P., Pisitkun, T., & Sriswasdi, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847756 · Cited by 9
Sun, Q., Huang, Z.-Q., Yang, S., Li, Y., Ma, Y., Yang, F., Zhang, Y., & Xu, F. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152287 · Cited by 9
Generation of bispecific antibodies by structure-guided redesign of IgG constant regions
Iwasaki, Y. W., Tharakaraman, K., Subramanian, V., Khongmanee, A., Hatas, A., Fleischer, E., Rurak, T. T., Ngok-ngam, P., Tit-oon, P., Ruchirawat, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063002 · Cited by 9
Carter, B., Huang, P., Liu, G., Liang, Y., Lin, P. J. C., Peng, B.-H., McKay, L. G. A., Dimitrakakis, A., Hsu, J., Tat, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135815 · Cited by 10
Bhardwaj, P., Behera, S. P., Nanaware, N., Zaman, K., Deval, H., Kant, R., Kulkarni, S., Kumar, R., Dwivedi, G. R., & Singh, R. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03492-1 · Cited by 9
Meyer, M., Parpoulas, C., Barthélémy, T., Becker, J. P., Charoentong, P., Lyu, Y., Börsig, S., Bulbuc, N., Tessmer, C., Weinacht, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294565 · Cited by 9
Haller-Caskie, M., Bonczarowska, J. H., Rieger, D., Lenz, T. L., Nebel, A., & Krause‐Kyora, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691475 · Cited by 9
Direct identification of HLA‐presented CD8 T cell epitopes from transmitted founder HIV‐1 variants
Hare, J., Macharia, G. N., Yue, L., Streatfield, C., Hunter, E., Purcell, A. W., Ternette, N., & Gilmour, J. W. (2021) · PROTEOMICS · doi:10.1002/pmic.202100142 · Cited by 9
Computational approaches for vaccine designing
Awasthi, A., Sharma, G., & Agrawal, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00011-0 · Cited by 9
Liu, Y., Sun, B., Wang, J., Sun, H., Lü, Z., Chen, L., Lan, M., Xu, J., Pan, J., Shi, J., et al. (2022) · International Immunology · doi:10.1093/intimm/dxac006 · Cited by 9
HLA‐DRB1*03:01 is associated with female sex and younger age of anti‐LGI1 encephalitis
Liu, X., Guo, K., Lin, J., Gong, X., Li, A. Q., Zhou, D., & Hong, Z. (2022) · European Journal of Neurology · doi:10.1111/ene.15376 · Cited by 9
Non-invasive imaging of cell-based therapies using acoustic reporter genesPreprint
Shivaei, S., Liu, A., Abedi, M. H., Revilla, J., Daghlian, G., Hurvitz, I. U., Shen, H., Swift, M., & Shapiro, M. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.01.621111 · Cited by 9
A pan-cancer atlas of therapeutic T cell targetsPreprint
Li, G., Guzmán-Bringas, O. U., Sharma, A., Dellacherie, M. O., Sekhri, P., Yamin, R., Stepec, D., Burq, M., Clotea, I., Tardio, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.22.634237 · Cited by 9
Huang, J., Song, S., Yin, Y., He, Y., Wang, H., Gu, Y., He, L., Wang, X., Miao, X., Zhang, Z., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1528532 · Cited by 8
Evidence of focusing the MHC class I immunopeptidome by tapasin
Darley, R., Illing, P. T., Duriez, P. J., Bailey, A. G., Purcell, A. W., van Hateren, A., & Elliott, T. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563789 · Cited by 8
CD38 ‐Targeting Peptide Vaccine Ameliorates Aging‐Associated Phenotypes in Mice
Yu, S., Zhi-qiang, L., Tang, Y., Chen, Y., Ma, Y., Du, K., Zong, Z., Feng, K., Wei, Y., Chen, L., et al. (2025) · Aging Cell · doi:10.1111/acel.70147 · Cited by 8
Immunoinformatics-Based strategies for mRNA vaccine development against ilesha virus
Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Oluwasanya, G. J., Jimah, E. M., Iwalokun, B. A., Kolawole, O. M., Olotu, T. M., Awoyelu, E. H., Ganiyu, T. O., et al. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100046 · Cited by 8
MHCquant2 refines immunopeptidomics tumor antigen discovery
Scheid, J., Lemke, S., Gravel, N. H., Dengler, A., Sachsenberg, T. T., Declercq, A., Gabriels, R., Bauer, J., Wacker, M., Bichmann, L., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03763-8 · Cited by 8
Noman, A. A., Alhudhaibi, A. M., Sharma, P., Jannati, S. Z., Akhter, T., Siddika, S., Khan, K. F., Taha, T. H., Alsalamah, S. A., & Abdallah, E. M. (2025) · Pharmaceuticals · doi:10.3390/ph18111632 · Cited by 8
Ma, Y., Cai, Y., Yang, J., Zhao, Z., Chen, Z., Lv, D., Yu, J., Yang, C., Liu, K., Zeng, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116704 · Cited by 8
Kondrateva, O., Sonay, T. B., Zlobec, I., & Anisimova, M. O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582464 · Cited by 8
Molecular insights into early malignant transition of hepatocellular carcinoma
ZHANG, Z., li, H., Chen, L., Lu, T., Shentu, X., Liu, Y., Tang, Z., Ji, S., Qiu, Z., Zou, Y., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.03.005 · Cited by 9
Genetic background sets the trajectory of experimental cancer evolution
Aitken, S. J., Connor, F., Feig, C., Rayner, T. F., Lukk, M., Luft, J., Aitken, S., Arnedo-Pac, C., Hayes, J. V., Nicholson, M. D., et al. (2026) · Nature · doi:10.1038/s41586-026-10821-z · Cited by 8
Stanojevic, M., Geiger, A. E., Ostermeier, B., Sohai, D. K., Lazarski, C. A., Lang, H., Jensen-Wachspress, M. A., Webber, K., Burbelo, P. D., Cohen, J. I., et al. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.07.006 · Cited by 8
Lawrence, P. J., & Ning, X. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100293 · Cited by 8
Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
Vijver, S. V., Danklmaier, S., Pipperger, L., Gronauer, R., Floriani, G., Hackl, H., Das, K., & Wollmann, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1100730 · Cited by 8
White, B. S., Sindiri, S., Hill, V. K., Gasmi, B., Nah, S., Gartner, J. J., Prickett, T. D., Li, Y., Gurusamy, D., Robbins, P. F., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006303 · Cited by 8
Saravanakumar, S., & Chatterjee, J. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231193416 · Cited by 8
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
Cook, A. L., Sur, S., Dobbyn, L., Watson, E., Cohen, J. D., Ptak, B., Lee, B. S., Paul, S., Hsiue, E. H.-C., Popoli, M., et al. (2025) · eLife · doi:10.7554/elife.95952.3 · Cited by 8
Self-citationWeisbrod, L., Capriotti, L., Hofmann, M., Spieler, V., Dersch, H., Voedisch, B., Schmidt, P. M., & Knake, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386160 · Cited by 8
Struckman, N. E., de Jong, R. C. M., Honders, M. W., Smith, S.-A. I., van der Lee, D. I., Koutsoumpli, G., de Ru, A. H., Mikesch, J., van Veelen, P. A., Falkenburg, J. H. F., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12051086 · Cited by 8
Dayhimi, V., Ziadlou, F., Nafian, S., & Nafian, F. (2024) · Current Proteomics · doi:10.2174/0115701646302487240524103934 · Cited by 8
Elalouf, A., Maoz, H., & Yaniv‐Rosenfeld, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16080983 · Cited by 9
Ahmad, A., Karim, A., Arfah, R. A., Agus, R., Ladju, R. B., Hidayah, N., Massi, M. N., Nurhasanah, A., Karim, H., Handayani, I., et al. (2024) · Emerging Science Journal · doi:10.28991/esj-2024-08-04-07 · Cited by 8
Weitzen, M., Shahbazy, M., Kapoor, S., & Caron, É. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442783 · Cited by 8
Guan, X., Bu, F., Fu, Y., Zhang, H., Xiang, H., Chen, X., Chen, T., Wu, X.-J., Wu, K., Liu, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111338 · Cited by 8
Shaikh, S., Kunchala, D., Patel, M., Velecha, D., Prajapati, S., & Gupta, R. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.11.4067 · Cited by 8
Khan, J., Sadiq, A., Alrashed, M. M., Basharat, N., Mohani, S. N. U. H., Shah, T. A., Attia, K. A., Shah, A. A., Khan, H., Ali, I., et al. (2024) · BMC Molecular and Cell Biology · doi:10.1186/s12860-024-00524-6 · Cited by 8
Maldonado-Catala, P. J., Gouripeddi, R., Schlesinger, N., & Facelli, J. C. (2025) · ImmunoInformatics · doi:10.1016/j.immuno.2025.100050 · Cited by 8
Kasibhatla, S. M., Rajan, L. S., Shete, A. M., Jani, V., Yadav, S., Joshi, Y., Sahay, R. R., Patil, D. Y., Mohandas, S., Majumdar, T., et al. (2025) · PeerJ · doi:10.7717/peerj.18982 · Cited by 8
Saunders, P. M., Illing, P. T., Coin, L., Wong, S. C., Oates, C. V. L., Purcell, A. W., & Brööks, A. G. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf003 · Cited by 8
Jwo, S.-H., Ng, S.-K., Li, C.-T., Chen, S., Chen, L.-Y., Liu, P.-J., Wang, H.-J., Lin, J., Ko, C., Lee, C., et al. (2025) · Theranostics · doi:10.7150/thno.111400 · Cited by 8
Asadollahi, E., Zomorodipour, A., Soheili, Z., Jahangiri, B., & Sadeghizadeh, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1521700 · Cited by 8
Ullah, F., Ullah, S., Amin, M., Ullah, W., Ullah, S., & Wang, S. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111557 · Cited by 8
Quadiri, A., Lekbach, Y., Elfatimi, E., Prakash, S., Vahed, H., Karan, S., Rehman, A., Ng, S. X. L., Maurya, C., Chow, R., et al. (2025) · Vaccines · doi:10.3390/vaccines13090908 · Cited by 8
Fisher, R. J., Park, K., Lee, K., Pinjušić, K., Vanasse, A. P., Ennis, C. S., Farokh, P., Ficarro, S. B., Marto, J. A., Jiang, H., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190287 · Cited by 8
Castro, A., Öztürk, K., Zanetti, M., & Carter, H. K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246731 · Cited by 8
Vaccine Design and Immunoinformatics
Khan, F., & Kumar, A. (2021) · Springer eBooks · doi:10.1007/978-981-33-6191-1_8 · Cited by 8
Ogoshi, K., Takenoshita, S., & Isono, K. (2021) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.29.135 · Cited by 8
Ogoshi, K., Hayashi, F., Takenoshita, S., & Isono, K. (2022) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.30.55 · Cited by 8
Martínez‐Cortés, F., Domínguez‐Romero, A. N., Pérez-Hernández, E. G., Orozco-Delgado, D. L., Avila, S., Odales, J., Valle, J. G., Gevorkian, G., & Manoutcharian, K. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.03.019 · Cited by 8
Matos, A. S., Invenção, M. D. C. V., de Moura, I. A., de Freitas, A. C., & Batista, M. V. D. A. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2463 · Cited by 8
Shcherbinin, D. S., Карнаухов, В. К., Zvyagin, I. V., Chudakov, D. M., & Shugay, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224969 · Cited by 8
NeoHunter: Flexible software for systematically detecting neoantigens from sequencing data
Ma, T., Zhao, Z., Li, H., Wei, L., & Zhang, X. (2024) · Quantitative Biology · doi:10.1002/qub2.28 · Cited by 8
Larson, A. C., Knoche, S. M., Brumfield, G. L., Doty, K. R., Gephart, B. D., Moore-Saufley, P. R., & Solheim, J. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063211 · Cited by 8
López, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832889 · Cited by 8
Shedding light on the hidden human proteome expands immunopeptidome in cancer
Li, Y., Zhang, Y., Pan, T., Zhou, P., Zhou, W., Gao, Y., Zheng, S., & Xu, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac034 · Cited by 8
Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants
Ahmed, S. F., Sohail, M. S., Quadeer, A. A., & McKay, M. R. (2022) · Vaccines · doi:10.3390/vaccines10040542 · Cited by 8
Gandhamaneni, B. S., Krishnamoorthy, H. R., Veerappapillai, S., Mohapatra, S. R., & Ramanathan, K. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10083-7 · Cited by 8
Parn, S., Savsani, K., & Dakshanamurthy, S. (2022) · ImmunoInformatics · doi:10.1016/j.immuno.2022.100020 · Cited by 8
James, L. M., Charonis, S. A., & Georgopoulos, A. P. (2023) · Neuroscience Insights · doi:10.1177/26331055231166411 · Cited by 8
Conserved Evolution of MHC Supertypes among Japanese Frogs Suggests Selection for Bd Resistance
Lau, Q., Igawa, T., Kosch, T. A., Dharmayanthi, A. B., Berger, L., Skerratt, L. F., & Satta, Y. (2023) · Animals · doi:10.3390/ani13132121 · Cited by 8
Boughter, C. T., & Meier‐Schellersheim, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011577 · Cited by 8
Carter, J. A., Matta, B., Battaglia, J., Somerville, C. C., Harris, B. D., LaPan, M., Atwal, G. S., & Barnes, B. J. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007935 · Cited by 8
Marques, P. H., Tiwari, S., Felice, A. G., Jaiswal, A. K., Aburjaile, F. F., Azevedo, V., Silva-Vergara, M. L., Paim, K. F., Soares, S. D. C., & Fonseca, F. M. (2024) · Journal of Fungi · doi:10.3390/jof10010043 · Cited by 8
Thrift, W. J., Lounsbury, N., Broadwell, Q., Heidersbach, A. J., Freund, E. C., Abdolazimi, Y., Phung, Q. T., Chen, J., Capietto, A.-H., Tong, A.-J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.08.519673 · Cited by 8
Gulhan, D., Viswanadham, V., Muyas, F., Jin, H., Foote, M. B., Lee, J. J.-K., Barras, D., Jung, Y. L., Ljungström, V., Rousseau, B., et al. (2024) · medRxiv · doi:10.1101/2024.01.19.24301236 · Cited by 8
Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines
Yoon, J., Moon, H., Jeon, Y., Choe, S., & Yoon, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104559 · Cited by 7
Zhou, W., Yu, J., Li, F., Huang, Y.-T., Du, J., Wu, A., & Wang, K. (2025) · Blood Cancer Journal · doi:10.1038/s41408-025-01370-1 · Cited by 7
Nirob, M. N. H., Sultana, I., Arian, T. A., Islam, M. S., Moniruzzzaman, M., Nosi, S. J., Halder, S. K., Shil, A., & Himel, M. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334885 · Cited by 8
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia
Struckman, N. E., Koutsoumpli, G., de Jong, R. C. M., van der Lee, D. I., Remst, D. F. G., Smith, S.-A. I., Honders, M. W., Hagedoorn, R. S., de Ru, A. H., Matsuda, M., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02817-x · Cited by 7
Malone, M. J., Huang, C. M., Zhang, Y., Qi, Y., Williams, L., Su, L. F., Lou, J., & Jiang, N. J. (2025) · Nature Communications · doi:10.1038/s41467-025-67336-w · Cited by 7
ALi, A., Alamri, A. M., Mishra, V. K., Utegenova, A., Askarova, G., Baiduissenova, A., & Dusmagambetova, A. (2026) · BMC Immunology · doi:10.1186/s12865-025-00795-4 · Cited by 7
Martin, S. D., Elomaa, H., Väyrynen, J. P., Ahtiainen, M., Wirta, E., Böhm, J., Seppälä, T. T., Ristimaki, A. P., Tahkola, K., Mattila, A., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-025-03302-z · Cited by 7
Evolution of the tuberculin skin test reveals generalisable Mtb-reactive T cell metaclones
Turner, C. T., Tiffeau-Mayer, A., Rosenheim, J., Chandran, A., Saxena, R., Zhang, P., Jiang, J., Berkeley, M. I. K., Pang, F., Uddin, I., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68678-9 · Cited by 7
Decoding immunotherapy response through computational modeling
Li, B., Luo, R., Huang, K., Liu, J., Zhao, W., & Zhou, X. (2026) · Nature Communications · doi:10.1038/s41467-026-71364-5 · Cited by 7
Lin, Y., Ma, J., Yuan, H., Chen, Z., Xu, X., Jiang, M., Zhu, J., Meng, W., Qiu, W., & Liu, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae247 · Cited by 7
Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies
Rocha, L. G. D. N., Guimarães, P. A. S., Carvalho, M. G. R., & Ruiz, J. C. (2024) · Vaccines · doi:10.3390/vaccines12080836 · Cited by 7
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Yang, C., Trivedi, V., Dyson, K. A., Gu, T., Candelario, K. M., Yegorov, O., & Mitchell, D. A. (2024) · Genome Medicine · doi:10.1186/s13073-024-01363-y · Cited by 7
Khanam, A., Hridoy, H. M., Alam, M. S., Sultana, A., & Hasan, I. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36935 · Cited by 7
Katsushima, M., Nakayama, Y., Yoshida, T., Nishida, Y., Shirakashi, M., Nakashima, R., Yoshifuji, H., Ito, S., Satoh, J., Yamamoto, M., et al. (2024) · Rheumatology · doi:10.1093/rheumatology/keae476 · Cited by 7
Mi, X., Li, S., Ye, Z., Dai, Z., Ding, B., Sun, B., Shen, Y., & Xiao, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1478201 · Cited by 7
Gao, K., He, S., Shi, J., Xue, S. J., Li, X., & Sun, H. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c07528 · Cited by 7
Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein
Park, H.-T., Kingstad-Bakke, B. A., Cleven, T., Jung, M., Kawaoka, Y., & Suresh, M. (2025) · Journal of Virology · doi:10.1128/jvi.00867-24 · Cited by 7
Chowdhury, S., Jacobsen, C., Depledge, D. P., Wedemeyer, H. H., Sandmann, L., & Kefalakes, H. (2025) · Virus Evolution · doi:10.1093/ve/veaf012 · Cited by 7
Xiao, W., Gao, M., Mo, B., Huang, X., Du, Z., Wang, S., Chen, J., Luo, S., & Xing, H. (2025) · Pharmaceuticals · doi:10.3390/ph18040491 · Cited by 7
Machine learning approaches enable the discovery of therapeutics across domains
Chhibbar, P., & Das, J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.001 · Cited by 7
Oladipo, E. K., Adeyemo, S. F., Oshoneye, A. I., Akintola, H. B., Elegbede, B. I., Ayoomoba, T. U., Atilade, D. A., Adegboye, O. O., Ejikeme, A. E., Balogun, C. O., et al. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1562997 · Cited by 7
Pathogen Adaptation of HLA Alleles and Its Correlation with Autoimmune Diseases in the Han Chinese
Liu, S., Li, Y., Song, T., Zhang, J., Zhang, P., Luo, H., Zhang, S., Niu, Y., Xu, T., & He, S. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf038 · Cited by 7
Identification of shared neoantigens derived from frameshift mutations in the APC gene
Zhao, P., Effenberger, C., Matsumoto, S., Tanaka, T., Nakamura, Y., & Kiyotani, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1574955 · Cited by 7
Suneesh, N. S., Dhotre, K., Mahajan, P., Dass, D., Banerjee, A., Siddiqi, N. J., Malik, A., Joshi, M., Khan, A. A., Nema, V., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1586271 · Cited by 7
Design of a Multi-Valent SARS-CoV-2 Peptide Vaccine for Broad Immune Protection via Deep Learning
Feng, Z., Pang, X., Xu, Q., Gu, Z., Li, S., Zhu, L., & Li, H. (2025) · Engineering · doi:10.1016/j.eng.2025.04.025 · Cited by 7
Alissa, M., Alghamdi, A. A., Alghamdi, S. A., Alshehri, M. A., Aloraini, G. S., Albelasi, A., & Alshammari, M. S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144881 · Cited by 7
Chiaro, J., Peltonen, K., Õunap, K., Bailey, A., Feola, S., Wojciechowski, S., Es-Haghi, M., Azkargorta, M., Elortza, F., Russo, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01234-6 · Cited by 7
Evaluation of a multi-epitope vaccine PME for Pasteurella multocida in mouse model
Zhang, R., Dai, L., Jia, Y., Qi, H., He, J., Cheng, J., Gao, X., Lei, L., & Liu, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652907 · Cited by 7
Data-Independent Immunopeptidomics Discovery of Low-Abundant Bacterial Epitopes
Willems, P., Staes, A., Miret‐Casals, L., Demichev, V., Devos, S., & Impens, F. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00449 · Cited by 7
Chen, X., Hao, J., Li, Y., Zou, Y., Li, A., Fan, Y., Ma, S.-J., Hao, S., Yu, S., Shen, D., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114417 · Cited by 7
Shared PRAME epitopes are T-cell targets in NUT carcinoma
Jensen, J. L., Peterson, S. K., Sambade, M. J., Alley, J., Yu, S., Kinjo, T., Bennett, S., Vensko, S. P., II, Shabrang, M., DeBetta, J. D., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013539 · Cited by 7
Ghadaksaz, A., Fooladi, A. A. I., Hosseini, H. M., Satari, T. N., & Amin, M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1963318 · Cited by 7
In silicoscreening and epitope mapping of leptospiral outer membrane protein—Lsa46
Ibrahim, J. M., Shanitha, A., Nair, A. S., Oommen, O. V., & Sudhakaran, P. R. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2003247 · Cited by 7
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.